ATE326957T1 - Verwendung von tramadol zur verzögerung der ejakulation - Google Patents

Verwendung von tramadol zur verzögerung der ejakulation

Info

Publication number
ATE326957T1
ATE326957T1 AT02721427T AT02721427T ATE326957T1 AT E326957 T1 ATE326957 T1 AT E326957T1 AT 02721427 T AT02721427 T AT 02721427T AT 02721427 T AT02721427 T AT 02721427T AT E326957 T1 ATE326957 T1 AT E326957T1
Authority
AT
Austria
Prior art keywords
tramadol
ejaculation
delay ejaculation
delay
effective amount
Prior art date
Application number
AT02721427T
Other languages
English (en)
Inventor
David Bar-Or
Original Assignee
Dmi Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmi Biosciences Inc filed Critical Dmi Biosciences Inc
Application granted granted Critical
Publication of ATE326957T1 publication Critical patent/ATE326957T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Photolithography (AREA)
  • Liquid Crystal Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02721427T 2001-03-16 2002-03-15 Verwendung von tramadol zur verzögerung der ejakulation ATE326957T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27680601P 2001-03-16 2001-03-16

Publications (1)

Publication Number Publication Date
ATE326957T1 true ATE326957T1 (de) 2006-06-15

Family

ID=23058139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02721427T ATE326957T1 (de) 2001-03-16 2002-03-15 Verwendung von tramadol zur verzögerung der ejakulation

Country Status (18)

Country Link
US (2) US6974839B2 (de)
EP (1) EP1397126B9 (de)
JP (1) JP4377585B2 (de)
KR (1) KR100908350B1 (de)
CN (1) CN1289071C (de)
AT (1) ATE326957T1 (de)
AU (1) AU2002252361C1 (de)
CA (2) CA2440920C (de)
CY (1) CY1107478T1 (de)
DE (1) DE60211689T2 (de)
DK (1) DK1397126T5 (de)
ES (1) ES2265495T3 (de)
HK (1) HK1068549A1 (de)
MX (1) MXPA03008372A (de)
NZ (1) NZ528935A (de)
PT (1) PT1397126E (de)
WO (1) WO2002074241A2 (de)
ZA (1) ZA200308067B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074241A2 (en) * 2001-03-16 2002-09-26 Dmi Biosciences Inc. Method of delaying ejaculation
AU2003214800A1 (en) 2002-01-02 2003-07-24 Ardent Pharmaceuticals, Inc. Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
US7754767B2 (en) * 2002-11-06 2010-07-13 Trinity Laboratories, Inc. Method for treatment of premature ejaculation in humans
WO2004078143A2 (en) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
KR101086147B1 (ko) 2003-03-21 2011-11-25 넥스메드 홀딩스 인코포레이티드 조루증 치료용 조성물 및 치료 방법
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
JP5528705B2 (ja) * 2005-12-13 2014-06-25 トリニティ ラボラトリーズ インコーポレイテッド ヒトにおける早漏を治療するための方法
FR2907121B1 (fr) 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques
NZ579169A (en) * 2007-02-12 2012-05-25 Dmi Biosciences Inc Treatment of comorbid premature ejaculation and erectile dysfunction using tramadol and a phosphodiesterase (pde) inhibitor
KR20130122023A (ko) * 2007-02-12 2013-11-06 디엠아이 바이오사이언시스 인코포레이티드 트라마돌의 부작용을 감소시키는 방법
US20100120780A1 (en) * 2007-04-19 2010-05-13 Chandra Ulagaraj Singh Treatments for premature ejaculation in humans
US20090005319A1 (en) * 2007-07-01 2009-01-01 Barone Jr Frank V Topical compositions for delaying ejaculation and methods of using the same
KR101103118B1 (ko) * 2007-11-02 2012-01-04 동아제약주식회사 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
GR1007315B (el) * 2010-04-19 2011-06-14 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Υγρομορφη παρεντερικης χορηγησης συνθεση που περιλαμβανει τραμαδολη hci και παρακεταμολη
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations
US11000488B2 (en) 2019-03-22 2021-05-11 Syntrix Biosystems Inc. Treating pain using desmetramadol

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3830934A (en) 1967-07-27 1974-08-20 Gruenenthal Chemie Analgesic and antitussive compositions and methods
US4507323A (en) 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US4940731A (en) 1989-08-30 1990-07-10 Pfizer Inc. Method of treating premature ejaculation using sertraline
US5151448A (en) 1991-07-12 1992-09-29 Crenshaw Roger T Method for treating premature ejaculation
DE69215316T2 (de) 1991-09-06 1997-03-20 Mcneilab Inc Zusammensetzungen, die Tramadol und irgendein Kodein, Oxykoden oder Hydrokoden enthalten, und deren Verwendung
AU651247B2 (en) 1991-09-06 1994-07-14 Mcneilab, Inc. Composition comprising a tramadol material and acetaminophen and its use
US5223541A (en) 1991-09-13 1993-06-29 Mcneilab, Inc. Tramadol n-oxide material, enantiomers and compositions thereof, and their use
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5276042A (en) 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4329794C2 (de) 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
IT1264965B1 (it) 1993-11-12 1996-10-17 Giorgio Cavallini Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
DE19547766A1 (de) 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19601744C2 (de) 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
DE19601745C1 (de) 1996-01-19 1997-10-09 Gruenenthal Gmbh Verfahren zur Racematspaltung von Tramadol
DE19609847A1 (de) 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
IL119121A (en) 1996-08-22 2000-11-21 Chemagis Ltd Process for the purification of (RR-SS)-2-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexanol hydrochloride
DE19641576C1 (de) * 1996-10-09 1998-05-07 Gruenenthal Gmbh Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten
US5919826A (en) 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
AU6747698A (en) 1997-04-11 1998-11-11 Nippon Shinyaku Co. Ltd. Remedies for frequent urination and urinary incontinence
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US6037360A (en) 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US5922341A (en) 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6156342A (en) 1998-05-26 2000-12-05 Andex Pharmaceuticals, Inc. Controlled release oral dosage form
GB2340037A (en) 1998-07-30 2000-02-16 Glaxo Group Ltd Compositions comprising bupropion for the treatment of premature ejaculation
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
WO2000056309A1 (en) 1999-03-19 2000-09-28 Knoll Pharmaceutical Company Method of treating sexual dysfunction
EP1180021A4 (de) 1999-05-06 2005-01-19 Pentech Pharmaceuticals Inc Behandlung der prämaturen ejakulation und dazugehöriger kit
EP1671628B1 (de) 1999-09-03 2012-10-03 APBI Holdings, LLC Selektive Serotonin-Aufnahme Inhibitoren mit schnellem Wirkungseintritt zur Behandlung von sexueller Dysfunktionen
US6339105B1 (en) 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
WO2001034125A2 (en) * 1999-11-09 2001-05-17 Darwin Discovery Limited Therapeutic use and formulation of (-)-tramadol
US6630138B2 (en) 2000-02-11 2003-10-07 Eli Lilly And Company Protein C derivatives
US6369051B1 (en) 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
WO2002074241A2 (en) * 2001-03-16 2002-09-26 Dmi Biosciences Inc. Method of delaying ejaculation

Also Published As

Publication number Publication date
CN1520289A (zh) 2004-08-11
JP4377585B2 (ja) 2009-12-02
US6974839B2 (en) 2005-12-13
EP1397126B1 (de) 2006-05-24
US20020132857A1 (en) 2002-09-19
DK1397126T5 (da) 2007-05-21
CA2758923A1 (en) 2002-09-26
WO2002074241A2 (en) 2002-09-26
ES2265495T3 (es) 2007-02-16
ZA200308067B (en) 2005-03-30
PT1397126E (pt) 2006-10-31
CA2440920C (en) 2012-01-24
HK1068549A1 (en) 2005-04-29
KR100908350B1 (ko) 2009-07-20
EP1397126A2 (de) 2004-03-17
MXPA03008372A (es) 2004-11-12
US20060106113A1 (en) 2006-05-18
AU2002252361B2 (en) 2005-09-08
WO2002074241A3 (en) 2003-12-24
NZ528935A (en) 2004-10-29
EP1397126B9 (de) 2007-02-21
KR20040052490A (ko) 2004-06-23
CN1289071C (zh) 2006-12-13
EP1397126B2 (de) 2006-05-31
AU2002252361C1 (en) 2006-03-30
CY1107478T1 (el) 2013-03-13
JP2004532828A (ja) 2004-10-28
DE60211689D1 (de) 2006-06-29
EP1397126A4 (de) 2005-02-16
DK1397126T3 (da) 2006-10-02
DE60211689T2 (de) 2007-01-11
CA2440920A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
CY1107478T1 (el) Η χρηση της τραμαδολης για καθυστερηση της εκσπepματισης
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE60308996D1 (de) Melanocortinrezeptoragonisten
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
HK1051499A1 (en) Method for treating ocular pain
BR0316753A (pt) Método de tratamento para disfunção sexual
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE298542T1 (de) Vorrichtung zum fördern und verstärken der peniserektion
DE60108094D1 (de) Die verwendung von retinoid antagonisten oder agonisten für die behandlung von gelenk-und knochenpathologien
DE60005952D1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
BR0309009A (pt) Método para o tratamento de hipersecreção de muco
ATE314861T1 (de) Verwendung von antikörper gegen mag zur behandlung ischämischer schlaganfälle
AU2003291302A8 (en) Method for treatment of premature ejaculation in humans
DE602004024871D1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
DE60102812D1 (de) Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
DE60330233D1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten
DE60108241D1 (de) Felabamat-derivate zur behandlung von neuropathischem schmerz
DE60118363D1 (de) Methoden zur behandlung des kryptorchysmus
ATE396730T1 (de) Verwendung von levocetirizin zur behandlung von persistierender allergischer rhinitis
MXPA03010451A (es) Nuevos metodos para el tratamiento y prevencion del dolor.
DE60108775D1 (de) Methode zur behandlung von schlaganfall
ATE399551T1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1397126

Country of ref document: EP